Inventors Eye, a new electronic publication by the United States Patent and Trademark Office is a bimonthly publication for the independent inventor community.
According to the USPTO, Inventors Eye is for and about America’s independent and small entity inventor community. It is a community that has always been a vital and vibrant [...]

India and United States have signed two inter-governmental agreements on Intellectual Property Rights (IPR) to help prevent what they say is the misappropriation of traditional knowledge through mistaken issuance of patents, what some call biopiracy.
‘Biopiracy’ describes a process in which living resources or traditional knowledge and practices are patented, thus applying intellectual property restrictions to [...]

In the the Tafas v. Kappos lawsuit, Under Secretary of Commerce for Intellectual Property and Director of the United States Patent and Trademark Office David Kappos and the U.S. Patent and Trademark Office filed a joint motion for dismissal of the appeal and to vacate the judgment of the district court below because the USPTO [...]

The next quarterly meeting of the U.S. Patent and Trademark Office’s Biotechnology and Chemical Pharmaceutical Customer Partnership is scheduled:
Wednesday, December 9, 2009 from 10:00 am to 5:00 pm
Auditorium in Madison East, 600 Dulany Street, Alexandria, Virginia.
The Biotechnology and Chemical Pharmaceutical Customer Partnership is designed and developed to be a forum to share ideas, experiences, and [...]

Under Secretary of Commerce for Intellectual Property and Director of the USPTO David Kappos has officially rescinded the highly hated regulations that would have limited patented claims and continuations — with an emphasis on the fact that they were proposed by the previous administration. The regulations were published in the Federal Register in August [...]

David Kappos, Director of the US Patent and Trademark Office, made a series of proposals to bring change to the examiner count system – the process for determining the time a patent examiner has to complete a patent examination and how much credit is given for each stage of an examination.
The proposal was developed by [...]

The USPTO has prepared interim examination instructions for evaluating patent subject matter eligibility under 35 U.S.C. 101 (Interim Patent Subject Matter Eligibility Examination Instructions) pending a decision by the U.S. Supreme Court in Bilski v. Kappos, and invited the public to submit written comments on the Interim Patent Subject Matter Eligibility Examination Instructions on or [...]

The U.S. Patent and Trademark Office published a notice in the Federal Register inviting public comment regarding the Requirements for Patent Applications Containing Nucleotide Sequence and/or Amino Acid Sequence Disclosures (74 Fed. Reg. 40163).
Patent applications that contain nucleotide and/or amino acid sequence disclosures must include a copy of the sequence listing in accordance with the [...]